Company Analysis Laboratorios Farmaceuticos Rovi, S.A.
1. Summary
Advantages
- Dividends (2.73%) are higher than the sector average (1.7%).
- The stock's return over the last year (0%) is higher than the sector average (-48.69%).
- Current debt level 13.75% is below 100% and has decreased over 5 years from 16.57%.
- The company's current efficiency (ROE=25.83%) is higher than the sector average (ROE=14.54%)
Disadvantages
- Price (90.61 $) is higher than fair price (53.64 $)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Laboratorios Farmaceuticos Rovi, S.A. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -0.5% | 1.3% |
| 90 days | 0% | -21.2% | 4.3% |
| 1 year | 0% | -48.7% | 16% |
LABFF vs Sector: Laboratorios Farmaceuticos Rovi, S.A. has outperformed the "Healthcare" sector by 48.69% over the past year.
LABFF vs Market: Laboratorios Farmaceuticos Rovi, S.A. has significantly underperformed the market by -16.03% over the past year.
Stable price: LABFF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: LABFF with weekly volatility of 0% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Above fair price: The current price (90.61 $) is higher than the fair price (53.64 $).
Price is higher than fair: The current price (90.61 $) is 40.8% higher than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (32.61) is lower than that of the sector as a whole (46.22).
P/E vs Market: The company's P/E (32.61) is lower than that of the market as a whole (45.03).
5.2.1 P/E Similar companies
5.3. P/BV
P/BV vs Sector: The company's P/BV (7.68) is higher than that of the sector as a whole (5.41).
P/BV vs Market: The company's P/BV (7.68) is higher than that of the market as a whole (4.4).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (5.84) is higher than that of the sector as a whole (4.38).
P/S vs Market: The company's P/S indicator (5.84) is lower than that of the market as a whole (12.87).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (21.91) is higher than that of the sector as a whole (17.43).
EV/Ebitda vs Market: The company's EV/Ebitda (21.91) is lower than that of the market as a whole (23.89).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 38.71% over the last 5 years.
Earnings Slowdown: The last year's return (0.0629%) is below the 5-year average return (38.71%).
Profitability vs Sector: The return for the last year (0.0629%) exceeds the return for the sector (-1.62%).
6.4. ROE
ROE vs Sector: The company's ROE (25.83%) is higher than that of the sector as a whole (14.54%).
ROE vs Market: The company's ROE (25.83%) is lower than that of the market as a whole (51.15%).
6.6. ROA
ROA vs Sector: The company's ROA (17.6%) is higher than that of the sector as a whole (7.4%).
ROA vs Market: The company's ROA (17.6%) is lower than that of the market as a whole (35.83%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (14.06%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.88%).
8. Dividends
8.1. Dividend yield vs Market
High yield: The dividend yield of the company 2.73% is higher than the average for the sector '1.7%.
8.2. Stability and increase in payments
Dividend stability: The company's dividend yield 2.73% has been steadily paid over the past 7 years, DSI=0.83.
Weak dividend growth: The company's dividend yield 2.73% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (41.24%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
